Sexual Medicine Society of North America, Inc.

Scientific Program

Session type:
Person:
Clear filters

Thursday

Morning

09:00 a.m. - 12:00 p.m.
APN-PA Symposium
Location: Latour Ballroom 2
Moderator: Kenneth Mitchell, MPAS, PA-C

09:00 a.m. - 09:30 a.m.
RN Role in a Sexual Medicine Practice
Amy L. Dispennette, RN

09:30 a.m. - 10:00 a.m.
Ethical Challenges in Sexual Medicine: A Unique Case Study
Kenneth Mitchell, MPAS, PA-C

10:00 a.m. - 10:15 a.m.
Conducting Research
Danuta I. Dynda, MD

10:15 a.m. - 10:45 a.m.
ICD-10
Susanne Talebian, CHBC, RMM, CMOM, CPC-I, CPC, CUA, CCS-P, PCS

10:45 a.m. - 12:00 p.m.
Penile Rehabilitation Panel Discussion
Kenneth Mitchell, MPAS, PA-C & Joseph B. Narus, DNP, APRN, NP-BC


Afternoon

12:00 p.m. - 01:30 p.m.
Industry Sponsored Lunch
Location: Mouton


01:30 p.m. - 01:45 p.m.
Opening Statements
Location: Latour Ballroom 2
Moderators: Lawrence S. Hakim, MD, FACS & Tobias S. Köhler, MD, MPH


01:45 p.m. - 02:45 p.m.
Oncology and Sexuality: Non-Prostate Cancers
Location: Latour Ballroom 2
Moderators: John Mulhall, MD & Run Wang, MD

01:45 p.m. - 02:05 p.m.
Breast Cancer and Sexual Health
Don S. Dizon, MD

02:05 p.m. - 02:25 p.m.
Gyne Cancers and Sexual Health
Michael Krychman, MD

02:25 p.m. - 02:45 p.m.
Testis Cancer and Sexual Health
Michael L. Eisenberg, MD


02:45 p.m. - 03:30 p.m.
Therapy in Couples with Prostate Cancer: Why Men with Prostate Cancer don’t do Therapy?
Location: Latour Ballroom 2
Moderators: Stanley Althof, PhD & Linda L. Banner, PhD

02:45 p.m. - 03:00 p.m.
CaP and the Mental/Sexual Well-Being of Male Partners
Christian Nelson, PhD

03:00 p.m. - 03:15 p.m.
CaP and the Mental/Sexual Well-Being of Female Partners
Sharon J. Parish, MD, IF, NCMP

03:15 p.m. - 03:30 a.m.
Interventions enhancing Couples’ Sexual Intimacy after Prostate Cancer Treatment
Daniela Wittmann, PhD, LMSW


03:30 p.m. - 04:00 p.m.
Coffee Break
Location: Latour Ballroom 3, 5, 6 & 7


04:00 p.m. - 04:40 p.m.
Sexuality in Pregnancy and beyond
Location: Latour Ballroom 2
Moderator: Sharon J. Parish, MD, IF, NCMP

04:00 p.m. - 04:20 p.m.
Sexuality, Sexual Desire, and New Mothers
Tami Rowen, MD, MS

04:20 p.m. - 04:40 p.m.
Physical Therapy for Sexual Wellness Post-Pregnancy
Stephanie Prendergast, MPT


04:40 p.m. - 05:00 p.m.
Persistent Genital Arousal Disorder
Location: Latour Ballroom 2
Moderators: Stanley Althof, PhD & Irwin Goldstein, MD

04:40 p.m. - 05:00 p.m.
Neurobiology and Etiology of PGAD
James G. Pfaus, PhD


05:00 p.m. - 05:45 p.m.
Hypoactive Sexual Desire Disorder
Location: Latour Ballroom 2
Moderators: Stanley Althof, PhD & Irwin Goldstein, MD

05:00 p.m. - 05:22 p.m.
The Challenges of Diagnosing Low Sexual Desire in Women
Stanley Althof, PhD

05:23 p.m. - 05:45 p.m.
Pharmacologic options for treating HSDD: What’s on the Bench and What’s on the Bedside?
Sheryl A. Kingsberg, PhD


Evening

05:45 p.m. - 07:45 p.m.
Welcome Reception
Location: Latour Ballroom 3, 5, 6 & 7


Friday

Morning

07:00 a.m. - 08:00 a.m.
Industry Sponsored Breakfast
Location: Mouton


08:00 a.m. - 09:00 a.m.
Surgery for Female Sexual Concerns
Location: Latour Ballroom 2
Moderators: Seth Cohen, MD, MPH & Michael Krychman, MD

08:00 a.m. - 08:20 a.m.
Reconstruction after FGC
Crista E. Johnson-Agbakwu, MD, MSc

08:20 a.m. - 08:40 a.m.
Management of Sexual Pain
Irwin Goldstein, MD

08:40 a.m. - 09:00 a.m.
Cosmetic Genital Surgery
Christine Hamori, MD


09:00 a.m. - 09:30 a.m.
History of Penile Surgery for ED
Location: Latour Ballroom 2
Moderators: William O. Brant, MD & Lawrence S. Hakim, MD, FACS

09:00 a.m. - 09:15 a.m.
History of Vascular Surgery for ED
Ronald Virag, MD

09:15 a.m. - 09:30 a.m.
History of Prosthetic Surgery: F. Brantley Scott ED
David F. Mobley, MD


09:30 a.m. - 09:45 a.m.
Coffee Break
Location: Latour Ballroom 3, 5, 6 & 7


09:45 a.m. - 10:30 a.m.
Using Social Media to Promote your Practice
Location: Latour Ballroom 2
Moderator: Andrew C. Kramer, MD

09:45 a.m. - 10:00 a.m.
Using Social Media to Promote your Practice
Brian Steixner, MD

10:00 a.m. - 10:30 a.m.
Using Social Media to Promote your Practice
Farris K. Timimi, MD


10:30 a.m. - 11:30 a.m.
Medicolegal Issues in Sexual Medicine
Location: Latour Ballroom 2
Moderator: John Mulhall, MD

10:30 a.m. - 10:40 a.m.
How to Minimize Complications and Litigation in Penile Surgery
David Ralph, MS, FRCS

10:40 a.m. - 10:55 a.m.
The Anatomy of a Lawsuit – Avoiding Pitfalls
Mark E. Nichols, Esq.

10:55 a.m. - 11:10 a.m.
Mindset for Suit Survival
Luis Quintero, MD, FACEP

11:10 a.m. - 11:30 a.m.
Q&A


11:30 a.m. - 11:55 p.m.
AUA Update
Location: Latour Ballroom 2

11:30 a.m. - 11:45 p.m.
AUA Secretary Address
Manoj Monga, MD, FACS

11:45 a.m. - 11:55 a.m.
AUA Update - Research
Carolyn Best, PhD


11:55 a.m. - 12:00 p.m.
JSM Update
Location: Latour Ballroom 2
Moderator: John Mulhall, MD


Afternoon

12:00 p.m. - 01:30 p.m.
Special SMSNA Lunch Symposium on Hypogonadism (Independent Satellite Symposium, CME-certified)
Location: Mouton


01:30 p.m. - 02:30 p.m.
ESSM Symposium on Peyronie’s Disease: What’s next?
Location: Latour Ballroom 2
Moderator: David Ralph, MS, FRCS

01:30 p.m. - 01:47 p.m.
Phenotypic Screening for Peyronie's Disease: A new hope for new therapeutics?
Selim Cellek, MD, PhD

01:47 p.m. - 02:04 p.m.
Patients bother in Peyronie's Disease
Yacov Reisman, MD, PhD

02:04 p.m. - 02:19 p.m.
The 2015 ICSM Guidelines for Peyronie’s Disease
David Ralph, MS, FRCS

02:20 p.m. - 02:30 p.m.
Minimally Invasive Treatment of PD with PRP and Hyaluronic Acid
Ronald Virag, MD


01:30 p.m. - 02:30 p.m.
Use of Androgens in Women
Location: Margaux 1
Moderators: Irwin Goldstein, MD & Michael Krychman, MD

01:30 p.m. - 01:50 p.m.
Actions of Testosterone in Women
Noel N. Kim, PhD

01:50 p.m. - 02:10 p.m.
Testosterone Therapy in Women: The Evidence
Sharon J. Parish, MD, IF, NCMP

02:10 p.m. - 02:30 p.m.
Testosterone in Women with History of Gyne/Breast Cancers
Mindy E. Goldman, MD


01:30 p.m. - 02:30 p.m.
Basic Science of Priapism: New Paradigms
Location: Margaux 2
Moderators: Arthur L. Burnett II, MD & Biljana Musicki, PhD

01:30 p.m. - 02:00 p.m.
Pathophysiology of Priapism
Kelvin Davies, BSc, MSc, PhD

02:00 p.m. - 02:30 p.m.
Clinical Applications of Basic Science in Priapism
Arthur L. Burnett II, MD


01:30 p.m. - 04:00 p.m.
APN-PA Hands-on Stations
Location: Lafleur 2
Moderator: Kenneth Mitchell, MPAS, PA-C

01:30 p.m. - 02:00 p.m.
Testopel
Peter Veneziano, PA

02:00 p.m. - 02:30 p.m.
Xiaflex
Joseph B. Narus, DNP, APRN, NP-BC

02:30 p.m. - 03:00 p.m.
Coding
Susanne Talebian, CHBC, RMM, CMOM, CPC-I, CPC, CUA, CCS-P, PCS

03:00 p.m. - 03:30 p.m.
Penile Injections
Kevin Flinn, RN

03:30 p.m. - 04:00 p.m.
Male Genital Exam
Jeffrey Albaugh, PhD, APRN, CUCNS


02:30 p.m. - 03:00 p.m.
Off Label Management of Testosterone Deficiency
Location: Latour Ballroom 2
Moderators: Andrew R. McCullough, MD & Charles Welliver, MD

02:30 p.m. - 02:45 p.m.
Anastrazole
Alexander W. Pastuszak, MD, PhD

02:45 p.m. - 03:00 p.m.
HCG
Landon W. Trost, MD


02:30 p.m. - 04:00 p.m.
Moderated Posters: Basic Science I
Location: Margaux 2
Moderators: Kelvin Davies, BSc, MSc, PhD & Johanna Hannan, PhD

02:30 p.m. - 02:37 p.m.
Neuronal and Sonic Hedgehog Regulation of Collagen Abundance and Development in the Penis (#014)
Carol A. Podlasek, PhD

02:37 p.m. - 02:44 p.m.
Sepiapterin Supplementation Fails to Ameliorate Diesel Exhaust Particle Exposure-Related Erectile and Coronary Artery Dysfunction in Young Lewis Rats (#015)
C.J. Wingard

02:44 p.m. - 02:51 p.m.
Development of a High-Throughput, Cell-Based Assay for Anti-Myofibroblast Activity in Peyronie’s Disease (#016)
M. Mateus

02:51 p.m. - 02:58 p.m.
Development of Gene Therapy for Erectile Dysfunction: Delivery to Corpus Cavernosa using Viral Vectors (#017)
R. Terlecki

02:58 p.m. - 03:05 p.m.
Mirabegron Elicits Smooth Muscle Relaxation of Human and Rat Corpus Cavernosum Tissues via Non Nitric Oxide-cGMP Pathways (#018)
F.A. Yafi

03:05 p.m. - 03:12 p.m.
Vascular Endothelial Growth Factor and Antioxidants Improve Erectile Function in Diabetic Rats (#019)
L. DeYoung

03:12 p.m. - 03:19 p.m.
Regulation of Sphingosine-1-Phosphate (S1P) Signaling Pathway in Rats and Humans and Alterations in Response to Pathologically-Induced Erectile Dysfunction (#020)
Michael E. DiSanto, PhD

03:19 p.m. - 03:26 p.m.
SDF-1 Treatment Promotes Neurite Outgrowth from the Major Pelvic Ganglion by Upregulating Neurotrophins (#021)
Nikolai Sopko, MD, PhD

03:26 p.m. - 03:33 p.m.
Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in the Pathogenesis of Peyronie’s Disease (#022)
L. DeYoung

03:33 p.m. - 03:40 p.m.
Harnessing the Role of Microtubules in Neural Regeneration to Improve Erectile Function Outcomes Following Cavernous Nerve Injury in a Rat Model of Radical Prostatectomy (#023)
Kelvin Davies, BSc, MSc, PhD

03:40 p.m. - 03:47 p.m.
TNF-alpha Inhibits Neurite Outgrowth from the Major Pelvic Ganglion by Inducing Apoptosis of Nitrergic Neurons Ex Vivo (#024)
H. Matsui

03:47 p.m. - 03:54 p.m.
New Methodology for Investigating Ejaculation Dysfunction: Measuring Intraluminal Seminal Vesicle Pressure in Rats with Telemetric Device (#025)
S.W. Lee

03:54 p.m. - 04:00 p.m.
The Effect of Dietary Iron Intake on Intratesticular Metal Concentrations (#026)
J.S. Gabrielsen


03:00 p.m. - 04:00 p.m.
Moderated Posters: Androgens I
Location: Latour Ballroom 2
Moderators: Selim Cellek, MD, PhD & Abraham Morgentaler, MD

03:00 p.m. - 03:05 p.m.
Diagnostic Accuracy of a Single Serum Testosterone Measurement: The False Negative Rate (#027)
X. Ni

03:05 p.m. - 03:10 p.m.
Efficacy and Pharmacokinetics of Oral Testosterone (LPCN 1021) in Hypogonadal Men (#028)
Irwin Goldstein, MD

03:10 p.m. - 03:15 p.m.
Testosterone Solution 2% for Erectile, Orgasmic and Ejaculatory Dysfunction in Hypogonadal Men (#029)
D.A. Paduch

03:15 p.m. - 03:20 p.m.
Dose Titration and Safety of Oral Testosterone in Hypogonadal Men: Results from the SOAR Study (#030)
Mohit Khera, MD

03:20 p.m. - 03:25 p.m.
Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo-Controlled Study (#031)
Gerald B. Brock, MD

03:25 p.m. - 03:30 p.m.
The Construct Validity of the Patient-Reported Outcome Instruments Sexual Arousal, Interest, and Drive Scale (SAID) and the Hypogonadism Energy Diary (HED) (#032)
D. Heiselman

03:30 p.m. - 03:35 p.m.
An Assessment Of The Impact Of Testosterone Supplementation Therapy On Hemoglobin A1C (HbA1C) Levels In Diabetic And Non-Diabetic Men (#033)
John Mulhall, MD

03:35 p.m. - 03:40 p.m.
Diagnostic Accuracy of a Single Serum Testosterone Measurement (#034)
X. Ni

03:40 p.m. - 03:45 p.m.
Improvement of Endothelial Function Following Initiation of Testosterone Replacement Therapy (#035)
D. Shoskes

03:45 p.m. - 03:50 p.m.
Assessment of Fasting and Varying Meal Fat Content on the Bioavailability of Oral Testosterone Undecanoate (LPCN 1021) in Hypogonadal Men (#036)
Mohit Khera, MD

04:45 p.m. - 04:50 p.m.
Twice Weekly Dosing of Injectable Testosterone Associated with Increased Erythrocytosis (#037)
S.J. Ohlander


04:00 p.m. - 05:00 p.m.
Industry Sponsored Reception
Location: Mouton


05:00 p.m. - 05:45 p.m.
ASMH Session
Location: Latour Ballroom 2
Moderators: Gregory A. Broderick, MD & Seth Cohen, MD, MPH

05:00 p.m. - 05:23 p.m.
Cardiovascular Disease and ED – How to Council Patients and What are the Next Steps
Martin Miner, MD

05:23 p.m. - 05:45 p.m.
Incorporating Cardiovascular Wellness/Men’s Health Promotion in Urologic Practice
Culley C. Carson III, MD, FACS, FRCS(hon)


05:00 p.m. - 06:00 p.m.
Moderated Posters: Priapism/Reconstruction
Location: Margaux 1
Moderators: Gerald B. Brock, MD & Robert C. Dean, MD

05:00 p.m. - 05:05 p.m.
Validation of the Priapism Profile Impact Questionnaire (#038)
B. Morrison

05:05 p.m. - 05:10 p.m.
A Retrospective Evaluation of the Safety and Effectiveness of a Silicone Block Implant for Elective Cosmetic Surgery of the Penis (#039)
O. Mirgoli

05:10 p.m. - 05:15 p.m.
Surgical Management of Acquired Buried Penis: Experience from Two Institutions (#040)
A. Herati

05:15 p.m. - 05:20 p.m.
Use of Phenylephrine in the Treatment of Ischemic Priapism: 5 year Experience at a Single Institution (#041)
D.G. Ridyard

05:20 p.m. - 05:25 p.m.
Buccal Mucosal Grafting in Peyronie’s Disease. Still not the Best (#042)
A. Zahran

05:25 p.m. - 05:30 p.m.
Complications and Surgical Management of Vaseline Injection Into the Penis for Girth Enhancement – A Photo Documentary: Support for the SMSNA’s Position on Penile Lengthening and Girth Enhancement. (#043)
Y. Krakowsky

05:30 p.m. - 05:35 p.m.
The Effect of Treatment for Priapism on Erectile Dysfunction (#044)
H. Levey Bernie

05:35 p.m. - 05:40 p.m.
Surgical Interventions for Priapism: The role of Penile Prostheses (#045)
M.J. Pagano

05:40 p.m. - 05:45 p.m.
Percutaneous Revision of a Testicular Prosthesis (#046)
M. Mendez

05:45 p.m. - 05:50 p.m.
Recovery of Glans Sensation Following Combined Dorsal and Ventral Onlay with a Glans Splitting Technique for Strictures of the Fossa Navicularis (#047)
M. Mendez

05:50 p.m. - 05:55 p.m.
Fertility Preservation in the Male to Female Transgender Patient: Role of Testis Sperm Extraction (TESE) and Testis Histology in Patients undergoing Gender Reassignment Surgery (#048)
S. Honig


05:00 p.m. - 06:00 p.m.
Moderated Posters: Epidemiology
Location: Margaux 2
Moderators: Maurice Garcia, MD, MAS & Mindy E. Goldman, MD

05:00 p.m. - 05:05 p.m.
Epidemiology of Penile Fractures in the Emergency Setting (#049)
S. Liu

05:05 p.m. - 05:10 p.m.
Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Intervention in Low-Risk Patients? (#050)
Lawrence C. Jenkins, MD, MBA

05:10 p.m. - 05:15 p.m.
Impact of Anal Sex Role on the HIV Protective Effect of Circumcision in MSM (#051)
D. Milam

05:15 p.m. - 05:20 p.m.
Testicular Torsion: Epidemiological Risk Factors for Orchiectomy in Pediatric and Adult Patients (#052)
G. Horn

05:20 p.m. - 05:25 p.m.
Evaluation of Doppler Parameters in Patients without Organic Erectile Dysfunction (#053)
Gregory A. Broderick, MD

05:25 p.m. - 05:30 p.m.
Post Finasteride Syndrome: Guess Who-Demographics from FDA Database (#054)
A. Lwin

05:30 p.m. - 05:35 p.m.
National Trends in the Diagnosis and Management of Psychogenic Erectile Dysfunction (#055)
D.J. Lee

05:35 p.m. - 05:40 p.m.
National Sex Survey in South Korea (#056)
D.G. Moon

05:40 p.m. - 05:45 p.m.
Changes in Erectile Dysfunction Over Time by age: A Community-Based Population Study (#057)
M.J. Ziegelmann

05:45 p.m. - 05:50 p.m.
Safe Space: LGBTQ training at the University of Miami (#058)
S. Kenya


Saturday

Morning

07:00 a.m. - 08:00 a.m.
Industry Sponsored Breakfast
Location: Mouton


08:00 a.m. - 08:40 a.m.
Pornography and Non-Normative Sexual Behavior: Where to draw the line?
Location: Margaux 2
Moderators: Michael A. Perelman, PhD & Jess Waldura, MD, MAS

08:00 a.m. - 08:20 a.m.
Who are you Calling Deviant: Prevalence of Non-Normative Sexual Interests
Jess Waldura, MD, MAS

08:20 a.m. - 08:40 a.m.
Internet Pornography: Harmful to Men and Relationships?
Nicole Prause, PhD


08:00 a.m. - 09:00 a.m.
Video Session for Peyronie’s Surgery
Location: Latour Ballroom 2
Moderators: Brian S. Christine, MD & Ashley H. Tapscott, DO

08:00 a.m. - 08:20 a.m.
How I do Penile Plication
Laurence A. Levine, MD

08:20 a.m. - 08:40 a.m.
How I do Patch Grafting
Wayne J.G. Hellstrom, MD

08:40 a.m. - 09:00 a.m.
How I Manage Residual Curvature after IPP in PD
Brian S. Christine, MD


08:00 a.m. - 09:00 a.m.
Molecular Pathways in ED: Where are we going?
Location: Margaux 1
Moderators: Nestor Gonzalez-Cadavid, PhD & Nikolai Sopko, MD, PhD

08:00 a.m. - 08:30 a.m.
Sonic Hedgehog
Carol A. Podlasek, PhD

08:30 a.m. - 09:00 a.m.
Stem Cells/Cytokines
Trinity J. Bivalacqua, MD, PhD


08:40 a.m. - 09:00 a.m.
Future Drugs and Treatment of PE
Location: Margaux 2
Moderators: Michael A. Perelman, PhD & Jess Waldura, MD, MAS

08:40 a.m. - 09:00 a.m.
Future Drugs and Treatment of PE
Chris McMahon, MD


09:00 a.m. - 10:00 a.m.
Moderated Posters: Erectile Dysfunction Surgical I
Location: Latour Ballroom 2
Moderators: LeRoy A. Jones Jr., MD & Edward Karpman, MD

09:00 a.m. - 09:04 a.m.
The Effect of Hypogonadism on Post-Prostatectomy Erectile Function in Men Treated with Penile Rehabilitation (#059)
D.J. Lee

09:04 a.m. - 09:08 a.m.
The Impact of Surgical Approach on Corporal Sizing for Inflatable Penile Prosthesis Insertion (#060)
M.J. Pagano

09:08 a.m. - 09:12 a.m.
The who, how and what of Real-World Penile Implants Patients in 2015: The propper (Prospective Registry of Outcomes with Penile Prosthesis for Erectile Restoration) Registry Baseline Data (#061)
G. Henry

09:12 a.m. - 09:16 a.m.
"Just the Tip" Closed Suction Drain Cultures after Implantation of Penile Prosthesis (#062)
J. Wallen

09:16 a.m. - 09:20 a.m.
Influential Factors for Penile Implant Patient Satisfaction at 1 year from the PROPPER Registry (#063)
Tobias S. Köhler, MD, MPH

09:20 a.m. - 09:24 a.m.
Risk Factors for Surgical Revision after Penile Prosthesis Surgery (#064)
M. Pineda

09:24 a.m. - 09:28 a.m.
Erectile Function and Urinary Bother Following Radical Prostatectomy (RP) (#065)
Christian Nelson, PhD

09:28 a.m. - 09:32 a.m.
Prospective Evaluation of Postoperative Penile Rehabilitation: Penile Morphology and Patient Satisfaction 2 Years Following Coloplast Titan Inflatable Penile Prosthesis (#066)
G. Henry

09:32 a.m. - 09:36 a.m.
Multi-Institutional and Lasting Results with the MoST (Modified Sliding Technique) for Penile Lengthening with Penile Prosthesis Insertion (#067)
A. Weinberg

09:36 a.m. - 09:40 a.m.
Subcoronal IPP can be Performed under Local Anesthesia (#068)
S.S.H. Park

09:40 a.m. - 09:44 a.m.
Penile Intracavernosal Pillars: Lessons from Anatomy and Potential Implications for Penile Prosthesis Placement (#069)
M.J. Pagano

09:44 a.m. - 09:48 a.m.
Placement of Penile Prosthesis May Improve Metabolic Syndrome: Retrospective Cohort in a Single Site Institutional Experience (#070)
L. Ramos


09:00 a.m. - 10:00 a.m.
Moderated Posters: Basic Science II
Location: Margaux 1
Moderators: Michael E. DiSanto, PhD & Alexander W. Pastuszak, MD, PhD

09:00 a.m. - 09:07 a.m.
PKA Agonist Colforsin Recovers Erectile Function and Promotes nNOS Signalling in the Penis in Cavernous Nerve Injury Rat Model (#072)
Arthur L. Burnett II, MD

09:07 a.m. - 09:14 a.m.
Neurotoxic M1 Macrophages are Recruited to the Major Pelvic Ganglion by Increased TNF-alpha Following Bilateral Cavernous Nerve Injury (#073)
H. Matsui

09:14 a.m. - 09:21 a.m.
S-Nitrosoglutathione Reductase (GSNOR) Protects against Western Diet Induced Reactive Oxygen Species Production and Erectile Dysfunction (#074)
J.D. La Favor

09:21 a.m. - 09:28 a.m.
Protective Effect of Herbal Formulation in the Bladder of Androgen-Deprived Rat (#075)
K.S. Kim

09:28 a.m. - 09:35 a.m.
Correlation between Androgen Receptor CAG Repeat Length Polymorphism and Metabolic Syndrome, Late Onset Hypogonadism in Korean Male (#076)
D.G. Moon

09:35 a.m. - 09:42 a.m.
Protective Effect of KH-204 via ERK and Akt Pathways in LOH Rat Model (#077)
K.S. Kim

09:42 a.m. - 09:49 a.m.
Further Evidence for a Role of Human Growth Hormone (hGH) in the Control of Penile Erection in the Adult Male (#078)
S. Ückert

09:49 a.m. - 09:56 a.m.
Separate or Combined Treatments with Human Bone Marrow-Derived Stem Cells and Substance P of Erectile Dysfunction in a Rat Model of Diabetes (#079)
G.H. Song


09:00 a.m. - 10:00 a.m.
Moderated Posters: Female Sexual Dysfunction / Mental Health
Location: Margaux 2
Moderators: Christian Nelson, PhD & Daniela Wittmann, PhD, LMSW

09:00 a.m. - 09:05 a.m.
Successful Management of Clitorodynia Closed Compartment Syndrome (#080)
S.A. King

09:05 a.m. - 09:10 a.m.
Sub-Urethral Sling Surgery For Stress Incontinence May Result In Orgasmic Dysfunction Through Direct Injury to Anterior Vaginal Wall, Peri-Urethral Prostatic Tissue (#081)
Irwin Goldstein, MD

09:10 a.m. - 09:15 a.m.
Responder Analyses Based on Minimum Clinically Important Differences Derived from Receiver Operating Characteristic Curves in Premenopausal Women Using Bremelanotide for Female Sexual Dysfunctions (#082)
Stanley Althof, PhD

09:15 a.m. - 09:20 a.m.
Partner Prosthesis Panic (#083)
S.A. King

09:20 a.m. - 09:25 a.m.
Have Related Between Female Sexual Function and Male Partners’ Erectile Function? (#084)
K. Drasa

09:25 a.m. - 09:30 a.m.
‘A Rose By Any Other Name’: Historical Insights into Restless Genital Syndrome (RGS) (#085)
B. Chubak

09:30 a.m. - 09:35 a.m.
The Impact of Testicular Loss on the Psychopathology of Young Patient in Korea: Population-based Analysis of 4 Million Examinees of Manpower Administration Database for 10 Years (#086)
S.W. Lee

09:35 a.m. - 09:40 a.m.
Sexual Behavior Seems to Influence Depression (#087)
F. Ramirez

09:40 a.m. - 09:45 a.m.
Sexual Abuse Increases Risk of Addictive Behaviors (#088)
F. Ramirez

09:45 a.m. - 09:50 a.m.
Emotional Intelligence in Persons Involved in Sexual Relationships Outside Marriage (#089)
F. Ramirez

09:50 a.m. - 09:55 a.m.
Vaginal Dilation: Current Use and Treatment Practices Vaginal Dilator Clinician Survey: Preliminary Report Health Care Provider Insight (#090)
Michael Krychman, MD

09:55 a.m. - 10:00 a.m.
Barriers to Sexual Activity after Treatment for Head and Neck Cancer: A Qualitative Approach (#091)
B. Rhoten


10:00 a.m. - 10:30 a.m.
Coffee Break
Location: Latour Ballroom 3, 5, 6 & 7


10:30 a.m. - 11:00 a.m.
2nd Annual Robert Krane Lecture: Neuroplasticity: Implications for ED
Location: Margaux 1
Moderator: Carol A. Podlasek, PhD

10:30 a.m. - 11:00 a.m.
2nd Annual Robert Krane Lecture: Neuroplasticity: Implications for ED
Trinity J. Bivalacqua, MD, PhD


10:30 a.m. - 11:00 a.m.
Contraception and Sexual Health
Location: Margaux 2
Moderators: Sue W. Goldstein, BA & Christian Nelson, PhD

10:30 a.m. - 10:45 a.m.
How Contraceptive Options Affect Women’s Sexual Enjoyment
Tami Rowen, MD, MS

10:45 a.m. - 11:00 a.m.
Condoms and Male Sexual Function
Brian Dodge, PhD


10:30 a.m. - 12:00 p.m.
Tips from the Masters: How I Perform Penile Implant Surgery
Location: Latour Ballroom 2
Moderators: Mark E. Leo, MD & John J. Mulcahy, MD, PhD

10:30 a.m. - 10:48 a.m.
How to do Infrapubic IPP
Edward Karpman, MD

10:48 a.m. - 11:06 a.m.
How I do Antibiotics, Retractor Placement, and Corporal Exposure
Rafael E. Carrion, MD

11:06 a.m. - 11:24 a.m.
How I Measure, Dilate, and Place Corporal Cylinders
Brian S. Christine, MD

11:24 a.m. - 11:42 a.m.
How I Place the Reservoir and Dress the Wound
Steven K. Wilson, MD

11:42 a.m. - 12:00 p.m.
How I Prevent Infection
William O. Brant, MD


11:00 a.m. - 12:00 p.m.
Moderated Posters: Erectile Dysfunction Medical
Location: Margaux 1
Moderators: Nelson Bennett Jr., MD & Ira D. Sharlip, MD

11:00 a.m. - 11:05 a.m.
A Comparison of Baseline Erectile Function after On-Demand 20 mg Tadalafil vs. Daily 5 mg Tadalafil in Men with Erectile Dysfunction and Diabetes: A Prospective, Observational 2-year Study (#092)
N.C. Park

11:05 a.m. - 11:10 a.m.
Prevalence of Sex Stimulants Abuse among Male Subjects in Calabar, Cross River State, Nigeria, Following Perceived Beneficial Effect in Increasing Genital Size (#093)
V.U. Nna

11:10 a.m. - 11:15 a.m.
Relationship Between Age and Erectile Dysfunction Diagnosis or Treatment Using Real-World Observational Data in the United States (#094)
John Mulhall, MD

11:15 a.m. - 11:20 a.m.
Efficacy and Safety of Sildenafil by Age in Men With Erectile Dysfunction (#095)
Irwin Goldstein, MD

11:20 a.m. - 11:25 a.m.
Penile Rehabilitation Adherence and Outcomes: The First 6 Months of Treatment (#096)
Jeffrey Albaugh, PhD, APRN, CUCNS

11:25 a.m. - 11:30 a.m.
Preservation of Nocturnal Penile Tumescense with Daily Low-Dose Sildenafil 6 Weeks after Nerve-Sparing Radical Prostatectomy is Correlated with Erectile Function Rehabilitation (#097)
A. Bannowsky

11:30 a.m. - 11:35 a.m.
Prevalence and Predictors of Erectile Dysfunction in Men Evaluated for Infertility (#098)
C.D. Gaffney

11:35 a.m. - 11:40 a.m.
The Prevalence And Predictors Of Vasovagal Reactions In Men Being Trained In Penile Injection Therapy (#099)
John Mulhall, MD

11:40 a.m. - 11:45 a.m.
End Diastolic Velocity versus Resistive Indices in Predicting Better Clinical Response Using Penile Doppler Ultrasound for Patients with Erectile Dysfunction (#100)
C. McCraw

11:45 a.m. - 11:50 a.m.
Determining Factors Associated with Early Onset of Erectile Dysfunction (ED) in Men with Type 1 Diabetes (#101)
M.R. Palmer

11:50 a.m. - 11:55 a.m.
Sex & Intimacy after Prostate Cancer Treatment: What Men and Partners Say (#102)
Jeffrey Albaugh, PhD, APRN, CUCNS

11:55 a.m. - 12:00 p.m.
Does the Gender of the Primary Care Physician Influence whether they Inquire about Erectile Dysfunction? (#103)
M. Bickell


11:00 a.m. - 12:00 p.m.
Moderated Posters: BPH/Ejaculation/Orgasm
Location: Margaux 2
Moderators: Seth Cohen, MD, MPH & Michael A. Perelman, PhD

11:00 a.m. - 11:05 a.m.
Orgasm in Men on Androgen Deprivation Therapy (ADT) for Prostate Cancer (#104)
John Mulhall, MD

11:05 a.m. - 11:10 a.m.
Daily Modafinil Treatment may be Beneficial for the Treatment of Lifelong Premature Ejaculation (#105)
E.C. Serefoglu

11:10 a.m. - 11:15 a.m.
The Significance of Testosterone Levels and the Efficacy of Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms (#106)
N.C. Park

11:15 a.m. - 11:20 a.m.
Impact of Endogenous Hormonal Status on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5mg for LUTS/BPH (#108)
C. Donatucci

11:20 a.m. - 11:25 a.m.
Prostatic Urethral Lift: BPH Treatment for the Sexually Inclined (#109)
J. Beilan

11:25 a.m. - 11:30 a.m.
The Effect of Hyaluronic Acid/Carboxymethylcellulose Instillation to Prevent Urethral Stricture after Transurethral Bladder Surgery (#110)
S.U. Jeh

11:30 a.m. - 11:35 a.m.
Relationship between Serum Testosterone and Nocturia in Men with Normal Prostate Size (#111)
J.S. Hyun

11:35 a.m. - 11:40 a.m.
Post-Finasteride Syndrome - Outcomes of FDA Database (#112)
M. Butcher


Afternoon

12:00 p.m. - 01:30 p.m.
Industry Sponsored Lunch
Location: Mouton


01:30 p.m. - 02:30 p.m.
Moderated Posters: Peyronie’s Disease
Location: Margaux 1
Moderators: Boback Berookhim, MD, MBA & Yacov Reisman, MD, PhD

01:30 p.m. - 01:34 p.m.
The Effect of Duration of Daily Penile Traction in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease (#113)
F.A. Yafi

01:34 p.m. - 01:38 p.m.
Penile Prosthesis Can Safely and Easily Be Inserted in Patients with Peyronie's Disease: Results of the PROPPER Study (#114)
Mohit Khera, MD

01:38 p.m. - 01:42 p.m.
Preliminary Data In A Longitudinal Analysis of the Psychological and Relationship Impact of Peyronie’s Disease (PD) (#115)
Lawrence C. Jenkins, MD, MBA

01:42 p.m. - 01:46 p.m.
Positive Results with Collagenase Clostridium histolyticum Treatment in Two Patients with Ventral Penile Curvature Due to Peyronie’s Disease (#116)
D. Milam

01:46 p.m. - 01:50 p.m.
Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie’s Disease (#117)
M.J. Ziegelmann

01:50 p.m. - 01:54 p.m.
Penile Prosthesis Ventral Extrusion: An Unforeseen Consequence of Penile Modeling in Peyronie’s Disease (#118)
S.C. Pate

01:54 p.m. - 01:58 p.m.
Peyronie's Disease Symptom Prevalence, Bother and Risk Factors in Dupuytren's Disease Patients (#119)
G.H. Sweet

01:58 p.m. - 02:02 p.m.
Erectile and Non-erectile Sexual Dysfunction in Men with Peyronie's Disease (#120)
I.C. Onyeji

02:02 p.m. - 02:06 p.m.
Characterizing Peyronie’s Disease And Its Response To Intralesional Verapamil In Men Developing Peyronie’s Disease After Radical Prostatectomy (#121)
Kelly Chiles, MD

02:06 p.m. - 02:10 p.m.
Assessing the Impact of Change in Penile Rigidity on Degree of Penile Curvature in Men with Peyronie’s Disease (PD) (#122)
Lawrence C. Jenkins, MD, MBA

02:10 p.m. - 02:14 p.m.
A Preliminary Report on Xiaflex Therapy Outcomes for Peyronie's Disease After a Year of Implementation at a Single REMS Institution (#123)
J. Fisher

02:14 p.m. - 02:18 p.m.
Dissecting the Peyronie’s Disease Questionnaire (PDQ): What Matters Most in the Initial Evaluation of Patients with Peyronie’s Disease ? (#124)
S. Honig

02:18 p.m. - 02:22 p.m.
Initial Peyronie’s Disease Questionnaire Bother Scores do not Correlate with Degree of Penile Curvature in Patients with Peyronie’s Disease (#125)
S. Honig

02:22 p.m. - 02:26 p.m.
Effects of Combination Therapy of Tamoxifen, L-carnitine and Daily PDE5 Inhibitors in the Peyronie's Disease (#126)
D.G. Moon


01:30 p.m. - 02:30 p.m.
Moderated Posters: Androgens II
Location: Margaux 2
Moderators: Serge Carrier, MD & Kenneth Mitchell, MPAS, PA-C

01:30 p.m. - 01:35 p.m.
High Dose Testosterone and Other Performance Enhancing Drug Use in Professional Male Bodybuilders Is Associated with Increased Mortality (#127)
A. Allison

01:35 p.m. - 01:40 p.m.
Testosterone Enanthate Administered Once-Weekly by Subcutaneous Auto Injector in Men with Hypogonadism: Pharmacokinetic and Safety Results from a Phase III Trial (#128)
J.C. Kaminetsky

01:40 p.m. - 01:45 p.m.
Comparison of the Effects of Oral Enclomiphene Citrate and Topical Testosterone Gels Treatment on Serum Hormones, Erythrocytosis, Lipids, and Prostate Specific Antigen (#129)
Alexander W. Pastuszak, MD, PhD

01:45 p.m. - 01:50 p.m.
Testosterone Inhibits the Growth of Prostate Cancer Xenografts in Nude Mice (#130)
Mohit Khera, MD

01:50 p.m. - 01:55 p.m.
Age and Body Mass Index are Independent Predictors of Testosterone Deficiency in Men with Erectile Dysfunction (#131)
M.J. Pagano

01:55 p.m. - 02:00 p.m.
The Ubiquitous Availability and Easy Acquisition of Illicit Anabolic Androgenic Steroids and Testosterone Preparations on the Internet (#132)
J.A. McBride

02:00 p.m. - 02:05 p.m.
Female Post-Finasteride Syndrome : It’s Not Just A Man’s World (#133)
J. Fiuk

02:05 p.m. - 02:10 p.m.
A Critical Evaluation of the Readability, Credibility, and Quality of High Ranking Websites Proclaiming to Provide Patient Centered Information on Hypogonadism (#134)
J.A. McBride

02:10 p.m. - 02:15 p.m.
Low Plasma Testosterone is Associated with Elevated Cardiovascular Disease Biomarkers (#135)
Alexander W. Pastuszak, MD, PhD

02:15 p.m. - 02:20 p.m.
Testosterone Replacement Therapy in Adolescents with Sickle Cell Disease Reverses Hypogonadism without Promoting Priapism (#136)
B. Morrison

02:20 p.m. - 02:25 p.m.
Low Dose Growth Hormone Releasing Peptide Treatment Does Not Increase Serum IGF-1 Levels in Men (#137)
M.C. Lindgren

02:25 p.m. - 02:30 p.m.
Effect of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men (#138)
D. Heiselman


01:30 p.m. - 03:30 p.m.
Sexual Health and Trauma: Recovering & Restoring Pleasure
Location: Latour Ballroom 2
Moderators: Gregory A. Broderick, MD, Hossein Sadeghi-Nejad, MD, FACS & Ira D. Sharlip, MD

01:30 p.m. - 01:50 p.m.
Sexual rehabilitation: Adaptive Strategies for Physical Limitations and Pain
Heather S. Howard, PhD, MPH

01:50 p.m. - 02:10 p.m.
Sexual Wellness in Veterans of Recent Wars
Benjamin N. Breyer, MD

02:10 p.m. - 02:30 p.m.
Fertility in Veterans of Recent Wars
Robert C. Dean, MD

02:30 p.m. - 02:45 p.m.
Presentation by wounded veteran

02:45 p.m. - 03:05 p.m.
Uropac and Urotrauma Bill
Robert C. Dean, MD

03:05 p.m. - 03:20 p.m.
SMSNA Legislative Affairs Committee

03:20 a.m. - 03:30 a.m.
Q&A


02:30 p.m. - 03:30 p.m.
Broadening the Patient Base
Location: Margaux 1
Moderators: David Latini, PhD & Tami Rowen, MD, MS

02:30 p.m. - 02:50 p.m.
Sexual Wellness in Transgender Persons
Maurice Garcia, MD, MAS

02:50 p.m. - 03:10 p.m.
BDSM and Alternative Relationships: A primer
Jess Waldura, MD, MAS

03:10 p.m. - 03:30 p.m.
Sexual Wellness in Gay Men: Beyond HIV Prevention
Billy H. Cordon, MD


02:30 p.m. - 03:30 p.m.
Moderated Posters: Erectile Dysfunction Surgical II
Location: Margaux 2
Moderators: William P. Conners, MD & Ronald W. Lewis, MD

02:30 p.m. - 02:34 p.m.
Subcutaneous Placement of Inflatable Penile Prosthesis Reservoirs (#149)
M. Bickell

02:34 p.m. - 02:38 p.m.
Complications of “Drained and Retained” Urologic Prosthetic Components (#139)
S.C. Pate

02:38 p.m. - 02:42 p.m.
Penile Prosthesis Implantation in Patients with Severe Corporal Fibrosis After Mechanical Therapy (#140)
P. Tsambarlis

02:42 p.m. - 02:46 p.m.
Use of Dorsal Nerve Block with Bupivacaine Liposome Injectable Suspension (Exparel) for Pain Management Following Three-Piece Penile Prosthesis Surgery (#141)
S.A. King

02:46 p.m. - 02:50 p.m.
Preoperative Local Anesthetic Block Reduces the Need for Narcotic Medications Following Penile Prosthesis Surgery (#142)
A. Weinberg

02:50 p.m. - 02:54 p.m.
Medium-term Outcomes of the MINT Technique for IPP Surgery in 180 Consecutive Patients (#143)
C. Love

02:54 p.m. - 02:58 p.m.
Preop vs. Postop Penile Length/Girth Maintenance and Satisfaction Following AMS 700 LGX Inflatable Penile Prosthesis Implantation (#144)
M. Gross

02:58 p.m. - 03:02 p.m.
A Contemporary Series of Penile Implant Complications Occurring at a Training Institution (#145)
J. Ring

03:02 p.m. - 03:06 p.m.
HIV-Positive Status does not Increase Risk of Penile Prosthesis Infection (#146)
N. Davoudzadeh

03:06 p.m. - 03:10 p.m.
Treatment Satisfaction after Penile Prosthesis Surgery is Higher for Virgin Cases Compared to Revision Cases (#147)
M. Pineda

03:10 p.m. - 03:14 p.m.
“The Wang Collar:” A Novel Post Operative Device after Inflatable Penile Prosthesis Placement (#148)
C. Benson

03:14 p.m. - 03:18 p.m.
A Streamline Approach to Inflatable Penile Prosthesis Placement (#150)
A. Weinberg

03:18 p.m. - 03:22 p.m.
Synchronous Dual AUS/IPP Insertion through a Single Penoscrotal Incision (#151)
F.A. Yafi

03:26 p.m. - 03:30 p.m.
Post-Prostatectomy Penile Prosthesis Reservoir Placement with Radiographic Guidance (#071)
D.G. Song


03:30 p.m. - 04:00 p.m.
Coffee Break
Location: Latour Ballroom 3, 5, 6 & 7


04:00 p.m. - 05:00 p.m.
ISSM Symposium
Location: Latour Ballroom 2
Moderator: Wayne J.G. Hellstrom, MD

04:00 p.m. - 04:15 p.m.
Perspectives in Testosterone Replacement Therapy (TRT)
Wayne J.G. Hellstrom, MD

04:15 p.m. - 04:30 p.m.
Xiaflex as a treatment for Peyronie`s Disease
Chris McMahon, MD

04:30 p.m. - 04:45 p.m.
ED as a Marker of Cardiovascular Disease
Luiz Otavio Torres, MD

04:45 p.m. - 05:00 p.m.
Is there really anything new in Male Sexual Health since the discovery of PDE5i's?
Gerald B. Brock, MD


05:00 p.m. - 05:30 p.m.
SMSNA Business Meeting (members only)
Location: Latour Ballroom 2


05:30 p.m. - 05:45 p.m.
SUPS Business Meeting (members only)
Location: Latour Ballroom 2


Evening

06:00 p.m. - 07:00 p.m.
Young Clinicians Mixer
Location: Montrachet Patio


Sunday

Morning

06:45 a.m. - 07:45 a.m.
ISSM Journals Session
Location: Latour Ballroom 2
Moderators: Irwin Goldstein, MD & John Mulhall, MD

06:45 a.m. - 07:15 a.m.
The Studies You Must Know About (JSM)
Kelly Chiles, MD

07:15 a.m. - 07:45 a.m.
The Studies You Must Know About (SMR/SM)
Alan W. Shindel, MD


07:45 a.m. - 09:15 a.m.
Best Abstracts Session
Location: Latour Ballroom 2
Moderators: Trinity J. Bivalacqua, MD, PhD & John Mulhall, MD

07:45 a.m. - 07:52 a.m.
Testosterone Replacement in Hypogonadal Men with Recent Coronary Artery Revascularization Improves Exercise Capacity (#001)
M.A. McLaughlin

07:52 a.m. - 07:59 a.m.
Engineering of Corporal Tissue Constructs using Non-Human Primate and Human Corpus Cavernosal Smooth Muscle and Endothelial Cells for Clinical Applications (#002)
R. Terlecki

07:59 a.m. - 08:06 a.m.
Novel Model of Ex-Vivo Mixed Lymphocyte Reaction to Assess the Effects of Rejection on Erectile Function in the Setting of Human Penile Transplantation (#003)
Nikolai Sopko, MD, PhD

08:06 a.m. - 08:13 a.m.
Post Finasteride Syndrome: Is dutasteride unfairly accused? (#004)
W. Baas

08:13 a.m. - 08:20 a.m.
Impact of Diabetes on Erectile Function Recovery (EFR) after Radical Prostatectomy (RP) (#005)
Lawrence C. Jenkins, MD, MBA

08:20 a.m. - 08:27 a.m.
Simplified Interpretation of the Erectile Function Domain of the International Index of Erectile Function (#006)
L. Tseng

08:27 a.m. - 08:34 a.m.
A Review of Microorganisms Isolated at Salvage or Explant of IPPs: Are We Covering the Correct Bugs? (#007)
M. Gross

08:34 a.m. - 08:41 a.m.
Submuscular Ectopic Inflatable Penile Prosthesis Reservoir Placement: A Cadaveric Study of Anatomic Location (#008)
M.J. Ziegelmann

08:41 a.m. - 08:48 a.m.
Lasofoxifene, a Selective Estrogen Receptor Modulator, as a Treatment for Sexual Dysfunction in Postmenopausal Women (#009)
Sheryl A. Kingsberg, PhD

08:48 a.m. - 08:55 a.m.
Pregnancy and Sexual relationships Study Involving wOmen and meN (PASSION study) (#010)
D. Dwarica

08:55 a.m. - 09:02 a.m.
Ultrasound Guided Treatment of Peyronie's Disease with Plasma Rich Platelets (PRP) and Hyaluronic Acid (HA) (#011)
Ronald Virag, MD

09:02 a.m. - 09:09 a.m.
Initial Experience with Peyronie's Plaque Excision and Grafting without Penile Degloving: An Update on the "Window" Technique (#012)
J.B. Emtage

09:09 a.m. - 09:15 a.m.
Effect of Hydroxyurea on Recurrent Ischemic Priapism in Jamaican Men with Sickle Cell Disease (#013)
B. Morrison


09:15 a.m. - 09:30 a.m.
SMSNA Awards/Prizes
Location: Latour Ballroom 2
Moderator: Tobias S. Köhler, MD, MPH


09:30 a.m. - 10:00 a.m.
Is there still a role for Duplex Ultrasound Scans in 2015
Location: Latour Ballroom 2
Moderator: Mohit Khera, MD

09:30 a.m. - 10:00 a.m.
Is there still a role for Duplex Ultrasound Scans in 2015
Gerald B. Brock, MD


10:00 a.m. - 11:00 a.m.
But No one told me!!! Career Advice for Junior Researchers/Clinicians
Location: Latour Ballroom 2
Moderator: Lawrence S. Hakim, MD, FACS

10:00 a.m. - 10:15 a.m.
Things to look for in… a Fellowship
Landon W. Trost, MD

10:15 a.m. - 10:30 a.m.
Things to look for in… a Post-Doc/Research Job
Johanna Hannan, PhD

10:30 a.m. - 10:45 a.m.
Things to look for in… a First Private Practice Job
William O. Brant, MD

10:45 a.m. - 11:00 a.m.
Things to look for in… a First Academic Job
Tobias S. Köhler, MD, MPH


11:00 a.m. - 11:50 a.m.
Take Home Messages
Location: Latour Ballroom 2
Moderator: Tobias S. Köhler, MD, MPH

11:00 a.m. - 11:10 a.m.
Erectile Dysfunction
Etai Goldenberg, MD

11:10 a.m. - 11:20 a.m.
Female Sexual Dysfunction / Mental Health / BPH / Ejaculation
Seth Cohen, MD, MPH

11:20 a.m. - 11:30 a.m.
Androgens
Charles Welliver, MD

11:30 a.m. - 11:40 a.m.
Reconstruction / Priapism / Peyronie's Disease
Brian Le, MD

11:40 a.m. - 11:50 a.m.
Basic Science
Alexander W. Pastuszak, MD, PhD


11:50 a.m. - 12:00 p.m.
Closing Remarks
Location: Latour Ballroom 2
Moderator: Tobias S. Köhler, MD, MPH


Tweets about the meeting

Our Services

About SMSNA

Established in 1994, our objective has been to promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of the anatomy, physiology, pathophysiology, diagnosis, and treatment...

~ Read More

Contact Us

SMSNA Executive Office
c/o Status Plus
+1 (952) 683 1917
+1 (612) 808 0491
info@smsna.org

Visit address
18466 Kenyon Avenue, Suite 2 on Lower Level
Lakeville, MN 55044

Mail address
PO Box 1233
Lakeville, MN 55044